Product safety data sheet - d00

Product Safety Data Sheet
Document
Version:
Description:
Issue
Date:
NOT CLASSIFIED AS HAZARDOUS ACCORDING TO CRITERIA OF NATIONAL OCCUPATIONAL Reckitt Benckiser (Australia) Pty Limited AFTER HOURS EMERGENCY TELEPHONE (5pm to 8am EST Australia): (02) 9857 2444 Lincoln Manor289 Lincoln RoadHenderson Auckland 1231 Each tablet contains Naproxen sodium 275mg.
Refer to MIMS for contraindications.
Dusts may cause irritation to the eye.
Dusts may cause irritation to the respiratory tract. This product may be ingested as medication when dosage instructions are followed. Not considered to cause discomfort through normal use.
The chronic toxicity of this product has not been determined.
Principal route of exposure is usually by ingestion. Prolonged treatment with non-steroidal anti-Inflammatory drugs (NSAIDs) has been associated with gastrointestinal irritation, erosion, ulceration, perforation, frank or occult bleeding, diarrhoea, constipation, and blood in the vomit or stool.
Chronic abuse of analgesics has been associated with nephropathy. Patients invariably have a history of regular ingestion of substantial or excessive doses over a period of years. In mild cases the condition is reversible. If experiencing a reaction seek medical attention .
Contact a doctor or a Poisons Information Centre immediately (Australia 13 1126, New Zealand 0800 764 766 or 0800 POISON).
Non combustible solid.
Not considered a significant fire risk, however containers may burn. Decomposes on heating and produces toxic fumes of carbon dioxide (CO2). Keep area well ventilated. Avoid generation of dusts.
Scoop up or vacuum spill and place into labelled containers for disposal.
Contain spill. Shovel material into labelled containers for disposal. Moisten product if dust generation is of concern. Do not allow material to enter waterways.
Store in a cool, well ventilated, dry area out of direct sunlight. Store below 30°C.
Exposure Standards have been set for the following ingredients: TWA = Time Weighted AverageSTEL= Short Term Exposure Limit1 Worksafe Australia Exposure Standards for Atmospheric Contaminants in the Occupational Environment [NOHSC:1003 1995)] Maintain air concentrations below exposure standards. Handle bulk tablets in an area serviced with dust extraction and a supply of clean airNone under normal operating conditions. When handling bulk tablets wear a face mask fitted with a P2 filter for particulate matter The toxicity of this product has not been determined. The ecotoxicity of this product has not been determined.
1. Recycle wherever possible or consult manufacturer for recycling options. 2. Consult State Land Waste Authority for disposal. 3. Bury or incinerate residue at an approved site. 4. Recycle containers if possible, or dispose of in an authorised landfill. This product has been registered with the Therapeutic Goods Administration (TGA); pending approval.
Regulatory, Safety & Environmental Services The information contained in this MSDS was compiled using the latest and most reliable information available to Reckitt Benckiser. The information is provided without any warranty, expressed or implied regarding its correctness or accuracy. Similarly no warranty expressed or implied regarding the product described herein shall be created by or inferred from any statement or omission from this MSDS nor will Reckitt Benckiser assume any liability for any loss or damage arising out of the use of this information. It is solely the responsibility of the user to determine safe conditions for use of this product and to assume liability for any loss, damage or expense whatsoever arising out of the product's improper use.
This document is only current on the day of viewing . Printed copies are UNCONTROLLED unless they are part of a Quality / Technical Manual or attached to a letter referring to a Purchase Order Number . END OF DOCUMENT

Source: http://www.rb-msds.com.au/uploadedFiles/pdf/Nurolasts%20Period%20Pain-v1-D0086951.pdf